Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Adults
Conditions
Interventions
HRS-9190 for Injection
Locations
1
China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Start Date
April 23, 2025
Primary Completion Date
August 13, 2025
Completion Date
August 13, 2025
Last Updated
March 6, 2026
Lead Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions